首页> 外文期刊>The American Journal of Cardiology >Symptom-Onset-To-Balloon Time, ST-Segment Resolution and In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in China: From China Acute Myocardial Infarction Registry
【24h】

Symptom-Onset-To-Balloon Time, ST-Segment Resolution and In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in China: From China Acute Myocardial Infarction Registry

机译:中国原发性经皮冠状动脉介入治疗ST段抬高型心肌梗死患者的症状发作至气球时间,ST段消退和住院死亡率:来自中国急性心肌梗死登记处

获取原文
获取原文并翻译 | 示例
       

摘要

Animal and imaging study evidence favors early reperfusion for acute myocardial infarction. However, in clinical trials, the effect of symptom-onset-to-balloon (S2B) time on clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) has been inconsistent. Moreover, there are few data regarding the ischemic time in China. A total of 3,877 consecutive patients with STEMI with available S2B time undergoing pPCI from January 2013 to September 2014 at 108 hospitals that participated in the China Acute Myocardial Infarction registry were included and stratified into 3 S2B groups: <6 hours, 6 to 12 hours, >12 hours S2B time was tested in multivariate logistic regression analyses as an independent risk factor of mortality (primary outcome), major adverse cardiovascular and cerebrovascular events (MACCE), and impaired myocardial perfusion (secondary outcomes). The median S2B time was 5.5 (3.75 to 8.50) hours. Longer S2B time was associated with higher in-hospital mortality (<6 hours: 2.7%; 6 to 12 hours: 3.4%; >12 hours: 4.9%; p = 0.047) and ST-segment resolution <50% (<6 hours: 16.7%; 6 to 12 hours: 19.2%; >12 hours: 24.3%; p = 0.002) but not MACCE. In multivariate-adjusted analysis, S2B >12 hours remained associated with ST-segment resolution <50% (odds ratio 1.53, 95% confidence interval 1.16 to 2.01, p = 0.002) but not with in-hospital mortality (odds ratio 1.673, 95% confidence interval 0.95 to 2.94, p = 0.073). In conclusion, median S2B time in patients with STEMI undergoing pPCI was longer than that in registry studies from other countries. Longer S2B time was associated with impaired myocardial perfusion but not with in-hospital mortality or MACCE. (C) 2016 Elsevier Inc. All rights reserved.
机译:动物和影像学研究证据支持急性心肌梗塞的早期再灌注。然而,在临床试验中,症状发作至气球发作(S2B)时间对接受原发性经皮冠状动脉介入治疗(pPCI)的ST段抬高型心肌梗死(STEMI)患者的临床结局影响尚不一致。此外,关于中国缺血时间的数据很少。从2013年1月至2014年9月,在参加中国急性心肌梗死登记处的108家医院中,总共3877名STEMI患者,有可用的S2B时间接受pPCI治疗,并分为3个S2B组:<6小时,6至12小时在多因素logistic回归分析中测试了> 12小时的S2B时间,作为死亡(主要结果),重大心血管和脑血管不良事件(MACCE)以及心肌灌注受损(次要结果)的独立危险因素。 S2B中位时间为5.5(3.75至8.50)小时。 S2B时间越长,院内死亡率越高(<6小时:2.7%; 6至12小时:3.4%;> 12小时:4.9%; p = 0.047),ST段分辨力<50%(<6小时) :16.7%; 6到12小时:19.2%;> 12小时:24.3%; p = 0.002),但不是MACCE。在多元校正分析中,S2B> 12小时仍与ST段分辨力<50%(赔率1.53,95%置信区间1.16至2.01,p = 0.002)相关,但与院内死亡率无关(赔率1.673,95 %置信区间0.95至2.94,p = 0.073)。总之,接受pPCI的STEMI患者中位S2B时间比其他国家的注册研究更长。 S2B时间的延长与心肌灌注受损有关,但与院内死亡率或MACCE无关。 (C)2016 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号